{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:25:58Z","timestamp":1794651958537,"version":"4.9.1"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11]]},"abstract":"<jats:p>An emerging group of high-grade renal cell carcinomas (RCCs), particularly carcinomas arising in the hereditary leiomyomatosis renal cell carcinoma syndrome (HLRCC), show <jats:italic toggle=\"yes\">fumarate hydratase<\/jats:italic> (<jats:italic toggle=\"yes\">FH<\/jats:italic>) gene mutation and loss of function. On the basis of similar cytomorphology and clinicopathologic features between these tumors and cases described as tubulocystic carcinomas with poorly differentiated foci (TC-PD) of infiltrative adenocarcinoma, we hypothesized a relationship between these entities. First, 29 RCCs with morphology of TC-PD were identified retrospectively and assessed for FH expression and aberrant succination (2SC) by immunohistochemistry (IHC), with targeted next-generation sequencing of 409 genes\u2014including <jats:italic toggle=\"yes\">FH<\/jats:italic>\u2014performed on a subset. The 29 TC-PD RCCs included 21 males and 8 females, aged 16 to 86 years (median, 46), with tumors measuring 3 to 21 cm (median, 9) arising in the right (n=16) and left (n=13) kidneys. Family history or stigmata of HLRCC were identifiable only retrospectively in 3 (12%). These tumors were aggressive, with 79% showing perinephric extension, nodal involvement in 41%, and metastasis in 86%. Of these, 16 (55%) demonstrated loss of FH by IHC (14\/14 with positive 2SC). In contrast, 5 (17%) showed a wild-type immunoprofile of FH+\/2SC\u2212. An intriguing group of 8 (28%) showed variable FH\u00b1 positivity, but with strong\/diffuse 2SC+. Next-generation sequencing revealed 8 cases with <jats:italic toggle=\"yes\">FH<\/jats:italic> mutations, including 5 FH\u2212\/2SC+ and 3 FH\u00b1\/2SC+ cases, but none in FH+\/2SC\u2212 cases. Secondly, we retrospectively reviewed the morphology of 2 well-characterized cohorts of RCCs with FH-deficiency determined by IHC or sequencing (n=23 and n=9), unselected for TC-PD pattern, identifying the TC-PD morphology in 10 (31%). We conclude that RCCs with TC-PD morphology are enriched for FH deficiency, and we recommend additional workup, including referral to genetic counseling, for prospective cases. In addition, based on these and other observations, we propose the term \u201cFH-deficient RCC\u201d as a provisional term for tumors with a combination of suggestive morphology and immunophenotype but where genetic confirmation is unavailable upon diagnosis. This term will serve as a provisional nomenclature that will enable triage of individual cases for genetic counseling and testing, while designating these cases for prospective studies of their relationship to HLRCC.<\/jats:p>","DOI":"10.1097\/pas.0000000000000719","type":"journal-article","created":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T09:23:30Z","timestamp":1474017810000},"page":"1457-1472","source":"Crossref","is-referenced-by-count":137,"title":["Tubulocystic Carcinoma of the Kidney With Poorly Differentiated Foci"],"prefix":"10.1097","volume":"40","author":[{"given":"Steven C.","family":"Smith","sequence":"first","affiliation":[{"name":"Departments of Pathology and Urology, VCU Health, Richmond, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiril","family":"Trpkov","sequence":"additional","affiliation":[{"name":"Calgary Laboratory Services and University of Calgary, Calgary, AB"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Bei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Mehra","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepika","family":"Sirohi","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chisato","family":"Ohe","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andi K.","family":"Cani","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"Hovelson","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Omata","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan B.","family":"McHugh","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Jochum","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Kantonsspital St. Gallen, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Colecchia","sequence":"additional","affiliation":[{"name":"Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitual","family":"Amin","sequence":"additional","affiliation":[{"name":"Department of Pathology, William Beaumont Health System, Royal Oak"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukul K.","family":"Divatia","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ond\u0159ej","family":"Hes","sequence":"additional","affiliation":[{"name":"Department of Pathology, Charles University and University Hospital, Plzen, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Menon","sequence":"additional","affiliation":[{"name":"Department of Pathology and Uro-oncology Disease Management Group, Tata Memorial Hospital, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela","family":"Werneck da Cunha","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology, A.C. Camargo Cancer Center, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Tripodi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Azienda Ospedaliera Universitaria Senese, Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi","family":"Brimo","sequence":"additional","affiliation":[{"name":"Department of Pathology, McGill University, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Gill","sequence":"additional","affiliation":[{"name":"Cancer Diagnosis and Pathology Group, Kolling Institue of Medical Research, Royal North Shore Hospital"},{"name":"Sydney Medical School, University of Sydney, Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeboye O.","family":"Osunkoya","sequence":"additional","affiliation":[{"name":"Department of Pathology, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Magi-Galluzzi","sequence":"additional","affiliation":[{"name":"Robert J. Tomsich Pathology and Laboratory Medicine Institute Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Sibony","sequence":"additional","affiliation":[{"name":"D\u00e9partement d\u2019Anatomie Pathologique, H\u00f4pital Cochin, Universit\u00e9 Paris Descartes, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean R.","family":"Williamson","sequence":"additional","affiliation":[{"name":"Department of Pathology, Henry Ford Health System, Detroit, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Nesi","sequence":"additional","affiliation":[{"name":"Division of Pathological Anatomy, University of Florence, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria M.","family":"Picken","sequence":"additional","affiliation":[{"name":"Department of Pathology, Loyola University, Maywood, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Maclean","sequence":"additional","affiliation":[{"name":"Douglass Hanly Moir Pathology, Macquarie Park, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Agaimy","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Friedrich-Alexander University, University Hospital, Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Pathology, Indiana University School of Medicine, Indianapolis, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan I.","family":"Epstein","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor E.","family":"Reuter","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish K.","family":"Tickoo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Tomlins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahul B.","family":"Amin","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/PAS.0b013e3181872d3f","article-title":"Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma","volume":"33","author":"Amin","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/PAS.0b013e318299f2d1","article-title":"The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia","volume":"37","author":"Srigley","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1016\/j.juro.2011.03.043","article-title":"Tubulocystic carcinoma of the kidney","volume":"185","author":"MacLennan","year":"2011","journal-title":"J Urol"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/his.12840","article-title":"Tubulocystic renal cell carcinoma is an entity that is immunohistochemically and genetically distinct from papillary renal cell carcinoma","volume":"68","author":"Tran","year":"2016","journal-title":"Histopathology"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/PAS.0b013e3181a13e7b","article-title":"Comparison of gene expression profiles in tubulocystic carcinoma and collecting duct carcinoma of the kidney","volume":"33","author":"Osunkoya","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/PAS.0b013e318150df1d","article-title":"Tubulocystic carcinoma of the kidney: clinicopathologic and molecular characterization","volume":"32","author":"Yang","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1097\/PAS.0b013e3181be22d1","article-title":"Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification","volume":"33","author":"Zhou","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.humpath.2012.11.015","article-title":"Tubulocystic carcinoma of the kidney with poorly differentiated foci: a series of 3 cases with fluorescence in situ hybridization analysis","volume":"44","author":"Al-Hussain","year":"2013","journal-title":"Hum Pathol"},{"key":"R11-20230922","first-page":"11124","article-title":"Tubulocystic renal cell carcinoma with poorly differentiated foci is indicative of aggressive behavior: clinicopathologic study of two cases and review of the literature","volume":"8","author":"Zhao","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/PAS.0b013e31804375b8","article-title":"The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome","volume":"31","author":"Merino","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2147\/IJNRD.S42097","article-title":"Hereditary leiomyomatosis and renal cell carcinoma","volume":"7","author":"Schmidt","year":"2014","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0000000000000163","article-title":"Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry","volume":"38","author":"Chen","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/cup.12396","article-title":"Fumarate hydratase immunohistochemical staining may help to identify patients with multiple cutaneous and uterine leiomyomatosis (MCUL) and hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome","volume":"41","author":"Llamas-Velasco","year":"2014","journal-title":"J Cutan Pathol"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1093\/hmg\/ddt639","article-title":"Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas","volume":"23","author":"Castro-Vega","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/PAS.0000000000000520","article-title":"Morphology and immunohistochemistry for 2SC and FH aid in detection of fumarate hydratase gene aberrations in uterine leiomyomas from young patients","volume":"39","author":"Joseph","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/PAS.0000000000000617","article-title":"Fumarate hydratase-deficient renal cell carcinoma is strongly correlated with fumarate hydratase mutation and hereditary leiomyomatosis and renal cell carcinoma syndrome","volume":"40","author":"Trpkov","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00428-015-1783-y","article-title":"Genetic testing of leiomyoma tissue in women younger than 30 years old might provide an effective screening approach for the hereditary leiomyomatosis and renal cell cancer syndrome (HLRCC)","volume":"467","author":"Martinek","year":"2015","journal-title":"Virchows Arch"},{"issue":"(suppl 2s)","key":"R20-20230922","article-title":"Hereditary leiomyomatosis and renal cell carcinoma (HLRCC)-associated renal cancer: a comparison of fumarate hydratase (FH) and S-(2-succino)-cysteine (2SC) immunohistochemistry as ancillary tools","volume":"211A","author":"Chen","year":"2015","journal-title":"Mod Pathol"},{"key":"R21-20230922","first-page":"260A","article-title":"Is tubulocystic carcinoma with dedifferentiation a form of HLRCC\/fumarate hydratase-deficient RCC?","volume":"suppl 2s","author":"Smith","year":"2015","journal-title":"Mod Pathol"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1097\/PAS.0b013e318299f0fb","article-title":"The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters","volume":"37","author":"Delahunt","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jmoldx.2014.09.008","article-title":"Assessing copy number alterations in targeted, amplicon-based next-generation sequencing data","volume":"17","author":"Grasso","year":"2015","journal-title":"J Mol Diagn"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00428-014-1699-y","article-title":"Tumor evolution and progression in multifocal and paired non-invasive\/invasive urothelial carcinoma","volume":"466","author":"Warrick","year":"2015","journal-title":"Virchows Arch"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13045-015-0204-7","article-title":"Comprehensive serial molecular profiling of an \u201cN of 1\u201d exceptional non-responder with metastatic prostate cancer progressing to small cell carcinoma on treatment","volume":"8","author":"Kadakia","year":"2015","journal-title":"J Hematol Oncol"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/annonc\/mdv134","article-title":"Integrative molecular profiling of routine clinical prostate cancer specimens","volume":"26","author":"Grasso","year":"2015","journal-title":"Ann Oncol"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2350-9-20","article-title":"The FH mutation database: an online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiency","volume":"9","author":"Bayley","year":"2008","journal-title":"BMC Med Genet"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2340\/0001555553409416","article-title":"Cutaneous leiomyomata with uterine leiomyomata","volume":"53","author":"Reed","year":"1973","journal-title":"Acta Derm Venereol"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1073\/pnas.051633798","article-title":"Inherited susceptibility to uterine leiomyomas and renal cell cancer","volume":"98","author":"Launonen","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","article-title":"Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer","volume":"30","author":"Tomlinson","year":"2002","journal-title":"Nat Genet"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PAS.0000000000000562","article-title":"Hereditary renal cell carcinoma syndromes: clinical, pathologic, and genetic features","volume":"39","author":"Adeniran","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R33-20230922","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.juro.2012.07.139","article-title":"Adrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancer","volume":"189","author":"Shuch","year":"2013","journal-title":"J Urol"},{"key":"R34-20230922","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s10689-014-9735-2","article-title":"Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment","volume":"13","author":"Menko","year":"2014","journal-title":"Fam Cancer"},{"key":"R35-20230922","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/PAI.0000000000000213","article-title":"Molecular genetic alterations in renal cell carcinomas with tubulocystic pattern: tubulocystic renal cell carcinoma, tubulocystic renal cell carcinoma with heterogenous component and familial leiomyomatosis-associated renal cell carcinoma. Clinicopathologic and molecular genetic analysis of 15 cases","volume":"24","author":"Ulamec","year":"2016","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R36-20230922","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ccr.2007.02.005","article-title":"Targeted inactivation of fh1 causes proliferative renal cyst development and activation of the hypoxia pathway","volume":"11","author":"Pollard","year":"2007","journal-title":"Cancer Cell"},{"key":"R37-20230922","first-page":"303872","article-title":"Abnormal cystic tumor in a patient with hereditary leiomyomatosis and renal cell cancer syndrome: evidence of a precursor lesion?","volume":"2015","author":"Ristau","year":"2015","journal-title":"Case Rep Urol"},{"key":"R38-20230922","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/jmg.2010.085068","article-title":"Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma","volume":"48","author":"Gardie","year":"2011","journal-title":"J Med Genet"},{"key":"R39-20230922","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/sj.bjc.6600502","article-title":"Low frequency of somatic mutations in the FH\/multiple cutaneous leiomyomatosis gene in sporadic leiomyosarcomas and uterine leiomyomas","volume":"87","author":"Barker","year":"2002","journal-title":"Br J Cancer"},{"key":"R40-20230922","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s13277-012-0391-6","article-title":"No evidence for the role of somatic mutations and promoter hypermethylation of FH gene in the tumorigenesis of nonsyndromic uterine leiomyomas","volume":"33","author":"Vaidya","year":"2012","journal-title":"Tumour Biol"},{"key":"R41-20230922","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0000000000000573","article-title":"Fumarate hydratase-deficient uterine leiomyomas occur in both the syndromic and sporadic settings","volume":"40","author":"Harrison","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R42-20230922","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa1505917","article-title":"Comprehensive molecular characterization of papillary renal-cell carcinoma","volume":"374","author":"Linehan","year":"2016","journal-title":"N Engl J Med"},{"key":"R43-20230922","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1158\/2159-8290.CD-12-0361","article-title":"ARID1A mutations in cancer: another epigenetic tumor suppressor?","volume":"3","author":"Wu","year":"2013","journal-title":"Cancer Discov"},{"key":"R44-20230922","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","year":"2013","journal-title":"Nature"},{"key":"R45-20230922","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature12965","article-title":"Comprehensive molecular characterization of urothelial bladder carcinoma","volume":"507","year":"2014","journal-title":"Nature"},{"key":"R46-20230922","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/modpathol.2014.86","article-title":"Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma","volume":"28","author":"Williamson","year":"2015","journal-title":"Mod Pathol"},{"key":"R47-20230922","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1097\/PAS.0000000000000292","article-title":"Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients","volume":"38","author":"Gill","year":"2014","journal-title":"Am J Surg Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201611000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:15:47Z","timestamp":1695420947000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201611000-00002"}},"subtitle":["A Frequent Morphologic Pattern of Fumarate Hydratase-deficient Renal Cell Carcinoma"],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000719","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}